Lindenwold Advisors INC acquired a new stake in Stevanato Group S.p.A. (NYSE:STVN – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 9,390 shares of the company’s stock, valued at approximately $229,000.
Other institutional investors have also bought and sold shares of the company. Hancock Whitney Corp lifted its position in shares of Stevanato Group by 4.8% during the first quarter. Hancock Whitney Corp now owns 11,482 shares of the company’s stock worth $234,000 after acquiring an additional 528 shares in the last quarter. Van Berkom & Associates Inc. lifted its position in shares of Stevanato Group by 33.3% during the first quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company’s stock worth $49,000 after acquiring an additional 600 shares in the last quarter. First Bank & Trust lifted its position in shares of Stevanato Group by 6.2% during the second quarter. First Bank & Trust now owns 16,142 shares of the company’s stock worth $394,000 after acquiring an additional 944 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its position in shares of Stevanato Group by 7.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,878 shares of the company’s stock worth $283,000 after acquiring an additional 1,004 shares in the last quarter. Finally, Whittier Trust Co. purchased a new stake in shares of Stevanato Group during the first quarter worth $27,000.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the company. William Blair restated an “outperform” rating on shares of Stevanato Group in a research report on Monday, June 30th. Weiss Ratings restated a “hold (c)” rating on shares of Stevanato Group in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Stevanato Group presently has a consensus rating of “Moderate Buy”.
Stevanato Group Price Performance
Shares of NYSE STVN opened at €23.85 on Friday. The firm has a market capitalization of $7.22 billion, a P/E ratio of 44.17, a P/E/G ratio of 2.30 and a beta of 0.57. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25. The stock’s 50-day simple moving average is €24.46 and its two-hundred day simple moving average is €23.55. Stevanato Group S.p.A. has a twelve month low of €17.12 and a twelve month high of €28.00.
Stevanato Group Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Stories
- Five stocks we like better than Stevanato Group
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 Heavily Shorted Stocks That Could Pop on Rate Cuts
- How to Short Nasdaq: An Easy-to-Follow Guide
- Broadcom Gets Second $420 Target as CPO Win Boosts Outlook
- What Are Some of the Best Large-Cap Stocks to Buy?
- PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.